These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 29370800)

  • 1. A novel immortalized hepatocyte-like cell line (imHC) supports in vitro liver stage development of the human malarial parasite Plasmodium vivax.
    Pewkliang Y; Rungin S; Lerdpanyangam K; Duangmanee A; Kanjanasirirat P; Suthivanich P; Sa-Ngiamsuntorn K; Borwornpinyo S; Sattabongkot J; Patrapuvich R; Hongeng S
    Malar J; 2018 Jan; 17(1):50. PubMed ID: 29370800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VIABILITY AND INFECTIVITY OF CRYOPRESERVED PLASMODIUM VIVAX SPOROZOITES.
    Patrapuvich R; Lerdpanyangam K; Jenwithisuk R; Rungin S; Boonhok R; Duangmanee A; Yimamnuaychok N; Sattabongkot J
    Southeast Asian J Trop Med Public Health; 2016 Mar; 47(2):171-81. PubMed ID: 27244953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmodium vivax pre-erythrocytic stages and the latent hypnozoite.
    Zanghi G; Vaughan AM
    Parasitol Int; 2021 Dec; 85():102447. PubMed ID: 34474178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing Plasmodium vivax Resources for Liver Stage Study in the Peruvian Amazon Region.
    Orjuela-Sanchez P; Villa ZH; Moreno M; Tong-Rios C; Meister S; LaMonte GM; Campo B; Vinetz JM; Winzeler EA
    ACS Infect Dis; 2018 Apr; 4(4):531-540. PubMed ID: 29542317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver-stage fate determination in
    Vantaux A; Péneau J; Cooper CA; Kyle DE; Witkowski B; Maher SP
    Front Microbiol; 2022; 13():976606. PubMed ID: 36212849
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatic spheroids used as an in vitro model to study malaria relapse.
    Chua ACY; Ananthanarayanan A; Ong JJY; Wong JY; Yip A; Singh NH; Qu Y; Dembele L; McMillian M; Ubalee R; Davidson S; Tungtaeng A; Imerbsin R; Gupta K; Andolina C; Lee F; S-W Tan K; Nosten F; Russell B; Lange A; Diagana TT; Rénia L; Yeung BKS; Yu H; Bifani P
    Biomaterials; 2019 Sep; 216():119221. PubMed ID: 31195301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmodium vivax liver stage assay platforms using Indian clinical isolates.
    Subramani PA; Vartak-Sharma N; Sreekumar S; Mathur P; Nayer B; Dakhore S; Basavanna SK; Kalappa DM; Krishnamurthy RV; Mukhi B; Mishra P; Yoshida N; Ghosh SK; Shandil R; Narayanan S; Campo B; Hasegawa K; Anvikar AR; Valecha N; Sundaramurthy V
    Malar J; 2020 Jun; 19(1):214. PubMed ID: 32571333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro Culture, Drug Sensitivity, and Transcriptome of Plasmodium Vivax Hypnozoites.
    Gural N; Mancio-Silva L; Miller AB; Galstian A; Butty VL; Levine SS; Patrapuvich R; Desai SP; Mikolajczak SA; Kappe SHI; Fleming HE; March S; Sattabongkot J; Bhatia SN
    Cell Host Microbe; 2018 Mar; 23(3):395-406.e4. PubMed ID: 29478773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of a human hepatocyte line that supports in vitro development of the exo-erythrocytic stages of the malaria parasites Plasmodium falciparum and P. vivax.
    Sattabongkot J; Yimamnuaychoke N; Leelaudomlipi S; Rasameesoraj M; Jenwithisuk R; Coleman RE; Udomsangpetch R; Cui L; Brewer TG
    Am J Trop Med Hyg; 2006 May; 74(5):708-15. PubMed ID: 16687667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A recombinant antibody against Plasmodium vivax UIS4 for distinguishing replicating from dormant liver stages.
    Schafer C; Dambrauskas N; Steel RW; Carbonetti S; Chuenchob V; Flannery EL; Vigdorovich V; Oliver BG; Roobsoong W; Maher SP; Kyle D; Sattabongkot J; Kappe SHI; Mikolajczak SA; Sather DN
    Malar J; 2018 Oct; 17(1):370. PubMed ID: 30333026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azithromycin disrupts apicoplast biogenesis in replicating and dormant liver stages of the relapsing malaria parasites Plasmodium vivax and Plasmodium cynomolgi.
    Amanzougaghene N; Tajeri S; Franetich JF; Ashraf K; Soulard V; Bigeard P; Guindo CO; Bouillier C; Lemaitre J; Relouzat F; Legrand R; Kocken CHM; Zeeman AM; Roobsoong W; Sattabongkot J; Yang Z; Snounou G; Mazier D
    Int J Antimicrob Agents; 2024 May; 63(5):107112. PubMed ID: 38367843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The
    Gupta DK; Dembele L; Voorberg-van der Wel A; Roma G; Yip A; Chuenchob V; Kangwanrangsan N; Ishino T; Vaughan AM; Kappe SH; Flannery EL; Sattabongkot J; Mikolajczak S; Bifani P; Kocken CH; Diagana TT
    Elife; 2019 May; 8():. PubMed ID: 31094679
    [No Abstract]   [Full Text] [Related]  

  • 13. Establishment of an in vitro assay for assessing the effects of drugs on the liver stages of Plasmodium vivax malaria.
    Chattopadhyay R; Velmurugan S; Chakiath C; Andrews Donkor L; Milhous W; Barnwell JW; Collins WE; Hoffman SL
    PLoS One; 2010 Dec; 5(12):e14275. PubMed ID: 21151554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Culture of exoerythrocytic stages of the malaria parasites Plasmodium falciparum and Plasmodium vivax.
    Cui L; Trongnipatt N; Sattabongkot J; Udomsangpetch R
    Methods Mol Biol; 2009; 470():263-73. PubMed ID: 19089388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice.
    Mikolajczak SA; Vaughan AM; Kangwanrangsan N; Roobsoong W; Fishbaugher M; Yimamnuaychok N; Rezakhani N; Lakshmanan V; Singh N; Kaushansky A; Camargo N; Baldwin M; Lindner SE; Adams JH; Sattabongkot J; Kappe SH
    Cell Host Microbe; 2015 Apr; 17(4):526-35. PubMed ID: 25800544
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Schäfer C; Zanghi G; Vaughan AM; Kappe SHI
    Annu Rev Microbiol; 2021 Oct; 75():87-106. PubMed ID: 34196569
    [No Abstract]   [Full Text] [Related]  

  • 17. Modeling the dynamics of Plasmodium vivax infection and hypnozoite reactivation in vivo.
    Adekunle AI; Pinkevych M; McGready R; Luxemburger C; White LJ; Nosten F; Cromer D; Davenport MP
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003595. PubMed ID: 25780913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum.
    Roth A; Maher SP; Conway AJ; Ubalee R; Chaumeau V; Andolina C; Kaba SA; Vantaux A; Bakowski MA; Thomson-Luque R; Adapa SR; Singh N; Barnes SJ; Cooper CA; Rouillier M; McNamara CW; Mikolajczak SA; Sather N; Witkowski B; Campo B; Kappe SHI; Lanar DE; Nosten F; Davidson S; Jiang RHY; Kyle DE; Adams JH
    Nat Commun; 2018 May; 9(1):1837. PubMed ID: 29743474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A microscale human liver platform that supports the hepatic stages of Plasmodium falciparum and vivax.
    March S; Ng S; Velmurugan S; Galstian A; Shan J; Logan DJ; Carpenter AE; Thomas D; Sim BK; Mota MM; Hoffman SL; Bhatia SN
    Cell Host Microbe; 2013 Jul; 14(1):104-15. PubMed ID: 23870318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KAI407, a potent non-8-aminoquinoline compound that kills Plasmodium cynomolgi early dormant liver stage parasites in vitro.
    Zeeman AM; van Amsterdam SM; McNamara CW; Voorberg-van der Wel A; Klooster EJ; van den Berg A; Remarque EJ; Plouffe DM; van Gemert GJ; Luty A; Sauerwein R; Gagaring K; Borboa R; Chen Z; Kuhen K; Glynne RJ; Chatterjee AK; Nagle A; Roland J; Winzeler EA; Leroy D; Campo B; Diagana TT; Yeung BK; Thomas AW; Kocken CH
    Antimicrob Agents Chemother; 2014; 58(3):1586-95. PubMed ID: 24366744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.